Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
EBS [NYSE]
Emergent BioSolutions Inc.
Healthcare | Drug Manufacturers - Specialty & Generic | USA
statements
Index- P/E10.84 EPS (ttm)5.63 Insider Own2.70% Shs Outstand53.30M Perf Week-1.68%
Market Cap3.38B Forward P/E12.18 EPS next Y5.01 Insider Trans-10.37% Shs Float45.20M Perf Month-23.02%
Income305.10M PEG1.18 EPS next Q2.29 Inst Own84.10% Short Float7.69% Perf Quarter-48.29%
Sales1.56B P/S2.18 EPS this Y445.20% Inst Trans0.03% Short Ratio4.14 Perf Half Y-33.03%
Book/sh28.57 P/B2.14 EPS next Y-43.97% ROA14.30% Target Price105.57 Perf Year-23.27%
Cash/sh9.87 P/C6.18 EPS next 5Y9.20% ROE28.60% 52W Range58.83 - 137.61 Perf YTD-31.91%
Dividend- P/FCF10.90 EPS past 5Y24.00% ROI14.30% 52W High-55.66% Beta0.99
Dividend %- Quick Ratio2.10 Sales past 5Y26.00% Gross Margin67.40% 52W Low3.71% ATR3.23
Employees2200 Current Ratio3.20 Sales Q/Q78.20% Oper. Margin34.80% RSI (14)31.80 Volatility3.45% 4.12%
OptionableYes Debt/Eq0.56 EPS Q/Q632.00% Profit Margin24.90% Rel Volume0.88 Prev Close59.10
ShortableYes LT Debt/Eq0.55 EarningsApr 29 AMC Payout0.00% Avg Volume839.71K Price61.01
Recom2.00 SMA20-10.88% SMA50-25.90% SMA200-37.47% Volume734,915 Change3.23%
May-05-21Downgrade Argus Buy → Hold
Apr-07-21Initiated The Benchmark Company Buy $150
Feb-24-21Upgrade Chardan Capital Markets Neutral → Buy $112
Feb-19-21Downgrade Chardan Capital Markets Buy → Neutral $112
Jan-08-21Downgrade Wells Fargo Overweight → Equal Weight $110
Sep-14-20Resumed JP Morgan Neutral $103
Jul-31-20Reiterated Chardan Capital Markets Buy $86 → $112
Sep-12-19Initiated Guggenheim Buy
Sep-04-19Upgrade Wells Fargo Market Perform → Outperform
Nov-02-18Upgrade Goldman Neutral → Buy
Aug-03-18Reiterated Chardan Capital Markets Buy $53 → $57
Jun-13-18Initiated Argus Buy $62
Apr-25-18Downgrade Wells Fargo Outperform → Market Perform
Jan-24-18Initiated Goldman Neutral
Jan-16-18Reiterated Chardan Capital Markets Buy $47 → $53
Jun-28-16Reiterated Singular Research Buy $44 → $40
Apr-15-16Initiated Chardan Capital Markets Buy $47
Mar-28-16Initiated Singular Research Buy $44
Feb-19-16Initiated Wells Fargo Outperform
May-15-14Initiated Summer Street Research Buy $35
May-05-21 07:45PM  
EBS INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline EBS
GlobeNewswire
06:28PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS
Newsfile
04:59PM  
EBS INVESTOR DEADLINE: HAGENS BERMAN, National Trial Attorneys, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Class Action Filed
Newsfile
04:05PM  
Emergent BioSolutions to Participate in Investor Conferences
GlobeNewswire
04:00PM  
LAWSUIT FILED: Emergent BioSolutions Inc. Sued for Violations of the Federal Securities Laws; Investors Should Contact Block & Leviton LLP
GlobeNewswire
03:31PM  
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS
Newsfile
01:50PM  
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
12:59PM  
EBS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Emergent Biosolutions Inc.
Newsfile
11:30AM  
DEADLINE ALERT for RMO, CS, FUV, EBS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
11:15AM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FGEN, EBS and CCIV
ACCESSWIRE
10:50AM  
Class Action Alert: Kessler Topaz Meltzer & Check, LLP Reminds EBS Investors for Securities Fraud Class Action Lawsuit
ACCESSWIRE
10:43AM  
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
06:10AM  
EBS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 18, 2021 in the Class Action Filed on Behalf of Emergent Biosolutions Inc. Limited Shareholders
Newsfile
May-04-21 11:15PM  
ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important Deadline - EBS
PR Newswire
10:50PM  
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CAN, CS, EBS and RMO
GlobeNewswire
04:50PM  
Why Emergent BioSolutions Stock Dropped 30% in April
Motley Fool
04:40PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS
Newsfile
04:29PM  
Kessler Topaz Meltzer & Check, LLP Reminds Emergent BioSolutions Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit
ACCESSWIRE
03:00PM  
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
02:15PM  
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates EBS, GOEV, SOS Investors on Securities Class Actions and Application Deadlines, Encourages Investors with Losses to Contact the Firm Now
ACCESSWIRE
10:55AM  
LAWSUITS FILED AGAINST DOX, CAN and EBS - Jakubowitz Law Pursues Shareholders Claims
ACCESSWIRE
10:54AM  
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
10:15AM  
Class Action Reminder: Labaton Sucharow LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (NYSE: EBS)
ACCESSWIRE
10:00AM  
EMERGENT SHAREHOLDERS: June 18, 2021 Filing Deadline in Class Action - Contact Lieff Cabraser
ACCESSWIRE
10:00AM  
EBS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Emergent BioSolutions Inc. Investors of Class Action and Encourages Investors to Contact the Firm
Newsfile
06:33AM  
Is Emergent BioSolutions Still a Buy After Its Coronavirus Vaccine Flub?
Motley Fool
06:30AM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VRM, GOEV and EBS
ACCESSWIRE
May-03-21 11:00PM  
SHAREHOLDER ALERT: CLAIMSFILER REMINDS EBS, GOEV, RMO, WKHS INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
GlobeNewswire
09:52PM  
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Class Action Filed, Application Deadline Approaching
GlobeNewswire
03:25PM  
EBS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 18, 2021 in the Class Action Filed on Behalf of Emergent Biosolutions Inc. Limited Shareholders
Newsfile
01:40PM  
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
01:30PM  
Lawsuits Filed Against LDOS, KRMD and EBS - Jakubowitz Law Pursues Shareholders Claims
ACCESSWIRE
01:04PM  
Shareholder Alert: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.
Newsfile
12:45PM  
ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of CAN, CS, EBS, RMO Investors, Lead Plaintiff Deadlines Set
ACCESSWIRE
11:10AM  
CLASS ACTION UPDATE for XL, FGEN and EBS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
10:49AM  
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
10:39AM  
52-Week Company Lows
GuruFocus.com
10:15AM  
EBS EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with LARGE LOSSES to Secure Counsel Before Important Deadline - EBS
ACCESSWIRE
09:35AM  
Class Action Reminder: Labaton Sucharow LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (NYSE: EBS)
ACCESSWIRE
06:08AM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS
Newsfile
May-02-21 10:15AM  
EBS EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces that a Securities Fraud Class Action Lawsuit was filed on Behalf of Investors of Emergent BioSolutions Inc.
GlobeNewswire
09:30AM  
Class Action Reminder: Labaton Sucharow LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (NYSE: EBS)
ACCESSWIRE
May-01-21 06:33PM  
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.
PR Newswire
05:00PM  
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important Deadline - EBS
Newsfile
11:00AM  
Class Action Reminder: Labaton Sucharow LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (NYSE:EBS)
ACCESSWIRE
07:40AM  
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
Apr-30-21 10:50PM  
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CAN, CS, EBS, RMO INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
GlobeNewswire
08:20PM  
UPDATE 1-Canada receives J&J's COVID-19 vaccine from plant where FDA halted production
Reuters
08:01PM  
Canada to not distribute JNJ COVID-19 vaccines until quality checks complete
Reuters
07:36PM  
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important Deadline EBS
GlobeNewswire
07:00PM  
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Class Action Filed, Application Deadline Approaching
ACCESSWIRE
05:55PM  
Emergent BioSolutions Inc. -- Moody's affirms Emergent's Ba2 CFR; revises outlook to negative
Moody's
02:35PM  
Emergent BioSolutions Has Supply Of 60M Johnson & Johnson COVID-19 Vaccine Doses Awaiting Approval: Bloomberg
Benzinga
02:30PM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VLDR, REGI and EBS
ACCESSWIRE
02:03PM  
Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (EBS)
Newsfile
01:15PM  
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
12:45PM  
LAWSUITS FILED AGAINST FGEN, CAN and EBS - Jakubowitz Law Pursues Shareholders Claims
ACCESSWIRE
12:30PM  
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Emergent BioSolutions Inc. (EBS)
Business Wire
11:40AM  
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
11:14AM  
Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within Days
Benzinga
11:00AM  
EBS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Emergent BioSolutions Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
ACCESSWIRE
11:00AM  
DEADLINE ALERT for FUV, EBS, and ACAD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
10:45AM  
Class Action Reminder: Labaton Sucharow LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (NYSE:EBS)
ACCESSWIRE
10:06AM  
Emergent (EBS) Beats on Q1 Earnings, Cuts Contract Revenue View
Zacks
10:05AM  
CLASS ACTION UPDATE for RIDE, FGEN and EBS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
09:19AM  
New Strong Sell Stocks for April 30th
Zacks
09:00AM  
EMERGENT INVESTORS: June 18, 2021 Filing Deadline in Class Action Contact Lieff Cabraser
Business Wire
06:30AM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PLUG, EBON and EBS
ACCESSWIRE
05:31AM  
Emergent BioSolutions Inc (EBS) Q1 2021 Earnings Call Transcript
Motley Fool
12:50AM  
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
Apr-29-21 11:02PM  
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline - EBS
PR Newswire
07:14PM  
EMERGENT BIOSOLUTIONS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Emergent BioSolutions Inc. - EBS
Newsfile
05:45PM  
Emergent Biosolutions (EBS) Q1 Earnings Top Estimates
Zacks
05:03PM  
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Fraud Class Action Filed, Application Deadline Established
Newsfile
04:55PM  
UPDATE 2-Emergent hopes to answer U.S. FDA on Baltimore plant within days
Reuters
04:19PM  
Emergent hopes to answer U.S. FDA on Baltimore plant within days
Reuters
04:13PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS
Newsfile
04:05PM  
Emergent BioSolutions Reports Financial Results for First Quarter 2021
GlobeNewswire
01:15PM  
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
12:30PM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PLUG, RIDE and EBS
ACCESSWIRE
11:35AM  
INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
11:11AM  
Emergent BioSolutions Inc. Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Deadline in Securities Fraud Class Action Lawsuit
ACCESSWIRE
11:00AM  
EBS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Emergent BioSolutions Inc. Investors of Class Action and Encourages Investors to Contact the Firm
Business Wire
10:25AM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLU, ATNX and EBS
ACCESSWIRE
09:30AM  
Class Action Reminder: Labaton Sucharow LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (NYSE: EBS)
ACCESSWIRE
09:01AM  
EMERGENT SHAREHOLDERS: June 18, 2021 Filing Deadline in Class Action Contact Lieff Cabraser
Business Wire
06:30AM  
CLASS ACTION UPDATE for SOS, FGEN and EBS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
Apr-28-21 10:50PM  
SHAREHOLDER ALERT: CLAIMSFILER REMINDS EBS, GOEV, RMO INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
GlobeNewswire
09:55PM  
EBS EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces that a Securities Fraud Class Action Lawsuit was filed on Behalf of Investors of Emergent BioSolutions Inc.
GlobeNewswire
09:00PM  
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Arcimoto, Emergent BioSolutions, and Verus International and Encourages Investors to Contact the Firm
GlobeNewswire
05:20PM  
SHAREHOLDER ALERT: MPLN KDMN EBS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
ACCESSWIRE
04:00PM  
Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. - EBS
GlobeNewswire
03:08PM  
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS
Newsfile
02:25PM  
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact Its Attorneys Now, Securities Fraud Case Pending, Firm Investigating CEOs Insider Sales
ACCESSWIRE
02:14PM  
EBS Stock: Berger Montague Investigates Potential Securities Fraud Claims Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021
Newsfile
01:00PM  
EBS INVESTOR ALERT: Shareholder Class Action Lawsuit Filed
Newsfile
12:45PM  
EBS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Emergent Biosolutions Inc.
Newsfile
11:02AM  
INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
11:00AM  
EBS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Emergent BioSolutions Inc. Investors of Class Action and Encourages Investors to Contact the Firm
ACCESSWIRE
11:00AM  
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Emergent BioSolutions Inc. (EBS)
Business Wire
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response products and solutions for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs). The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers ACAM2000, a smallpox vaccine; BioThrax, an anthrax vaccine; Vaxchora, a cholera vaccine; and Vivotif, a typhoid vaccine. The company also provides NARCAN for the emergency treatment of known or suspected opioid overdose; and Reactive Skin Decontamination Lotion Kit, a medical device to remove or neutralize chemical warfare agents from the skin. In addition, it offers raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to treat inhalational anthrax; Botulism Antitoxin Heptavalent for treating botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccination; and Trobigard a combination drug-device auto injector product candidate. Further, the company is developing COVID-EIG and COVID-HIG potential treatments to COVID-19 disease; and FLU-IGIV for the treatment of Influenza A infection in hospitalized patients. Additionally, it provides contract development and manufacturing service that comprises development services, drug substance manufacturing, and drug product manufacturing in the pharmaceutical and biotechnology industries, as well as the governments and non-governmental organizations. The company has collaboration agreements with Novavax Inc.; and Johnson & Johnson. Emergent BioSolutions Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bailey SueDirectorMar 04Sale92.378,168754,47824,427Mar 08 06:30 PM
Havey AdamEVP, Business OperationsMar 01Option Exercise40.9037,2791,524,81258,335Mar 03 06:07 PM
Havey AdamEVP, Business OperationsMar 01Sale99.3037,2793,701,64738,190Mar 03 06:07 PM
Kramer RobertPresident and CEOFeb 08Option Exercise30.7945,3971,397,961171,607Feb 09 05:23 PM
Kramer RobertPresident and CEOFeb 08Sale120.0345,3975,449,002139,210Feb 09 05:23 PM
Kramer RobertPresident and CEOJan 21Option Exercise26.4521,900579,255161,110Jan 22 04:14 PM
Kramer RobertPresident and CEOJan 21Sale110.0321,9002,409,657139,210Jan 22 04:14 PM
Kramer RobertPresident and CEOJan 20Option Exercise26.452,23259,036141,442Jan 22 04:14 PM
Kramer RobertPresident and CEOJan 20Sale110.002,232245,520139,210Jan 22 04:14 PM
Kramer RobertPresident and CEOJan 15Option Exercise25.6219,026487,446158,236Jan 19 04:28 PM
Kramer RobertPresident and CEOJan 15Sale106.0119,0262,016,901139,210Jan 19 04:28 PM
El-Hibri FuadChairmanNov 10Option Exercise26.4519,391512,8921,143,379Nov 12 06:30 PM
El-Hibri FuadChairmanNov 10Sale88.2119,3911,710,4801,123,988Nov 12 06:30 PM
El-Hibri FuadChairmanNov 09Option Exercise26.4520,000529,0001,143,988Nov 12 06:30 PM
El-Hibri FuadChairmanNov 09Sale95.2620,0001,905,2001,123,988Nov 12 06:30 PM
El-Hibri FuadChairmanNov 03Option Exercise26.4520,000529,0001,143,988Nov 04 08:53 PM
El-Hibri FuadChairmanNov 03Sale90.7420,0001,814,8001,123,988Nov 04 08:53 PM
El-Hibri FuadChairmanNov 02Option Exercise26.4520,000529,0001,143,988Nov 04 08:53 PM
El-Hibri FuadChairmanNov 02Sale90.4420,0001,808,8001,123,988Nov 04 08:53 PM
El-Hibri FuadChairmanSep 24Sale98.8512,5351,239,0851,123,988Sep 25 07:00 PM
El-Hibri FuadChairmanSep 23Sale100.5813,0001,307,5401,136,523Sep 25 07:00 PM
El-Hibri FuadChairmanSep 17Sale100.6820,0002,013,6001,149,523Sep 18 06:25 PM
El-Hibri FuadChairmanSep 16Sale102.4820,0002,049,6001,169,523Sep 18 06:25 PM
El-Hibri FuadChairmanSep 10Sale102.6620,0002,053,2001,189,523Sep 11 09:21 PM
El-Hibri FuadChairmanSep 09Sale102.8020,0002,056,0001,209,523Sep 11 09:21 PM
SULLIVAN LOUIS WDirectorSep 02Option Exercise20.087,893158,49150,655Sep 04 08:08 PM
SULLIVAN LOUIS WDirectorSep 02Sale111.2228,4183,160,60642,762Sep 04 08:08 PM
Bailey SueDirectorAug 18Sale128.314,665598,56432,595Aug 19 05:08 PM
Harsanyi ZsoltDirectorAug 17Sale133.716,609883,66424,579Aug 18 09:12 AM
JOULWAN GEORGE ADirectorAug 11Sale124.116,000744,63526,771Aug 12 04:52 PM
Zoon Kathryn CDirectorAug 10Sale130.271,000130,27012,489Aug 11 04:43 PM
Richard RonaldDirectorAug 07Sale131.006,297824,9078,276Aug 11 04:46 PM
Richard RonaldDirectorJun 03Sale87.516,572575,1424,269Jun 05 04:36 PM
Bailey SueDirectorJun 03Sale87.505,322465,69137,260Jun 05 04:33 PM
Hauer Jerome MDirectorMay 26Sale85.154,385373,37310,188May 27 05:10 PM
Zoon Kathryn CDirectorMay 26Sale85.104,093348,32213,489May 27 05:07 PM
Harsanyi ZsoltDirectorMay 14Option Exercise18.643,43464,01028,367May 18 07:12 PM
Zoon Kathryn CDirectorMay 12Sale85.211,660141,45414,761May 14 04:30 PM
Harsanyi ZsoltDirectorMay 11Sale81.994,940405,02524,933May 13 07:47 PM
JOULWAN GEORGE ADirectorMay 11Sale85.192,000170,37129,950May 13 07:45 PM
open in yahoo | open in reuters | open in marketwatch | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.